Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
about
Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor functionSpontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell linesDirect association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactionsOxidative inhibition of receptor-type protein-tyrosine phosphatase kappa by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytesOligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1Atypical polyproline recognition by the CMS N-terminal Src homology 3 domainMechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segmentPhospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signalingHomo- and heterodimerization of APP family members promotes intercellular adhesion.GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signalingPhosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cellsThe extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and RasHrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complexReaching out for signals: filopodia sense EGF and respond by directed retrograde transport of activated receptorsThe docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathwayNew targets for therapy in breast cancer: small molecule tyrosine kinase inhibitorsDual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.EGFR Signaling in Liver DiseasesEGFR signaling in renal fibrosisEnhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancerInhibition of Receptor Dimerization as a Novel Negative Feedback Mechanism of EGFR SignalingStructural basis for stem cell factor–KIT signaling and activation of class III receptor tyrosine kinasesA mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonistAdditional Serine/Threonine Phosphorylation Reduces Binding Affinity but Preserves Interface Topography of Substrate Proteins to the c-Cbl TKB DomainStructural basis of selectivity and neutralizing activity of a TGFα/epiregulin specific antibodySyntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalizationThe Cbl interactome and its functionsADAMs: key components in EGFR signalling and developmentModified epidermal growth factor receptor (EGFR)-bearing liposomes (MRBLs) are sensitive to EGF in solution1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapyMagnetic nanoparticles as mediators of ligand-free activation of EGFR signalingMembrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptorEpidermal growth factor induction of phenotype-dependent cell cycle arrest in vascular smooth muscle cells is through the mitogen-activated protein kinase pathwayProtein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerizationDimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissuesThe receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking siteA neutralizing RNA aptamer against EGFR causes selective apoptotic cell deathCbl promotes clustering of endocytic adaptor proteins.Enhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) Antibody Delivery via Pulsed Ultrasound with Targeting Microbubbles for Glioma Treatment
P2860
Q24293413-9AE4A78B-C93B-4A05-B164-73ABDF380D6AQ24293655-208A0F32-64C1-462D-95FA-44E308CF7B5FQ24297221-64BA459E-8ADC-4FF2-82C7-5B9A66878DD7Q24297516-F1A78F63-2D82-4AC0-A12C-909F5847A168Q24299715-4C8155CE-4B1C-4031-AD18-8F7229EC5788Q24305567-A939F146-E5C4-4705-8649-6483AA54E499Q24309071-A9BA7945-0896-4C0F-A66E-04B393C7BDDDQ24319008-6482F872-02C0-4540-AED7-70DBBB4FFDF5Q24337232-9D76E697-876B-49C9-AE52-876491F2F1B1Q24337649-53BD4C64-796C-41A1-8D62-44480E83E488Q24338435-252BB7AB-3684-4AD5-8C67-5B70AA3408F8Q24536067-FE739ECC-E1F9-4B59-9489-42A86E49D7D0Q24671862-E411DC32-1288-4135-BA6A-E9B5F4321821Q24675805-583EFC85-6971-4AA7-A216-1E6DC778F4FBQ24678987-7FE5F6FA-DD6E-47D7-BA49-77B23021434EQ24799816-0B684188-A97E-41CB-B57E-06CAE652D7ACQ24806486-453B2A5E-4F88-47C6-9728-16B6784A67D2Q24817218-814FF81A-E68F-43FD-87A3-804E4A0F7698Q26771265-6FCD7864-0CB4-457C-8B02-B37A62552358Q26796628-42F2F5B2-2368-41B8-865B-09DB9A15A3D9Q27305848-AAC45ABB-9A5D-4917-AFA0-D006DD30F5CBQ27314725-ABC64277-87BC-4425-833C-0CB0FCA08A68Q27643661-4EB14EA9-574A-4E07-AF29-3871E4DA586FQ27647900-39A9E77A-EB2E-4EA5-8780-A532B9D1AA02Q27664726-6B8D3F61-C821-4562-A915-0AABC63220E0Q27727718-2FC4A7E6-D9B9-410D-9DD3-F94D7793D850Q28118751-4549CDE0-626E-450F-9D3D-B74A5C12368FQ28277251-2D6FB4F9-DD71-44DD-B831-D0B6B3B61439Q28305519-90884CB5-5964-4C0C-80E9-528BDC9FAB4AQ28476290-5D7484E5-99B4-46A8-BA76-1910D7AFBF07Q28476652-9BACED09-CB1B-446F-A90E-A3DB04B315FAQ28534809-7A7B811B-B785-4AEE-A376-DE9DCA81A924Q28541111-E119BF0B-F7E2-49D6-8E37-B35FFF743F41Q28568347-F72EEFE1-5119-4357-B7F7-EA61F4365667Q28572036-8FF9783E-7164-4CAA-B9B1-5B4D0AD6E0EEQ28582095-EB0F73D0-CD13-4E82-801D-EAF6EEAC7B1AQ28645645-E1B51CE5-84A4-4106-B9A5-F88A8FEBF8ECQ28740749-0D2FD322-9F52-485F-81DE-4F95D7D6745EQ30160108-AB7E3692-6183-4239-9E5E-26FE3077A331Q30412519-3290057F-8C35-4C19-9795-BE7D339CA368
P2860
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
description
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im September 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/09/20)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/09/20)
@nl
наукова стаття, опублікована у вересні 2002
@uk
مقالة علمية (نشرت في 20-9-2002)
@ar
name
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@ast
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@en
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@nl
type
label
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@ast
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@en
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@nl
prefLabel
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@ast
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@en
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@nl
P3181
P1433
P1476
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
@en
P304
P3181
P356
10.1016/S0092-8674(02)00966-2
P407
P577
2002-09-20T00:00:00Z